HLS Therapeutics Inc.

HLS.TO·Toronto·Healthcare

Compare

4.1000−0.0400 (−0.97%)today

At close: Oct 16, 4:00 PM EDT · May be delayed up to 15 min · CAD

Key statistics

Previous close4.1400

Open4.1900

Day range4.06004.2000

52-week range0.00105.6200

Off day high−2.38%

Off 52-week high−27.05%

Volume15.11K

Avg. volume (3M)68.52K

Market cap126.83M

EPS (TTM)-0.3800

Forward P/E-41.26

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)0.76

Shares outstanding30.94M

Short interest—

Earnings dateAug 12, 2026

Analyst target7.4488

Profit margin−15.24%

Against its peers

Compare in full ›

	HLS.TO	AQST	CRDL	CPIX	IXHL	LFCR
Market cap	126.83M	474.43M	133.66M	107.58M	35.38M	241.84M
P/E (TTM)	—	—	—	—	—	—
Forward P/E	-41.3	-6.6	-4.8	51.3	-1.7	-8.2
Price/book	1.6	-8.4	7.5	6.2	0.5	-7.1
Dividend yield	—	—	—	—	—	—
1-year change	−27.05%	−42.66%	+4.76%	+101.69%	−75.26%	−3.77%
Today	−0.97%	−6.90%	−4.35%	−4.77%	−2.08%	−0.93%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to HLS.TO's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Aquestive Therapeutics, Inc.AQST · Drug Manufacturers - Specialty & Generic	474.43M	3.7800	−6.90%
Cardiol Therapeutics Inc.CRDL · Drug Manufacturers - Specialty & Generic	133.66M	1.1000	−4.35%
Cumberland Pharmaceuticals Inc.CPIX · Drug Manufacturers - Specialty & Generic	107.58M	7.18	−4.77%
Incannex Healthcare Inc.IXHL · Drug Manufacturers - Specialty & Generic	35.38M	2.8200	−2.08%
Lifecore Biomedical, Inc.LFCR · Drug Manufacturers - Specialty & Generic	241.84M	6.38	−0.93%
Medexus Pharmaceuticals Inc.MDP.TO · Drug Manufacturers - Specialty & Generic	153.99M	4.9000	+1.87%
China Pharma Holdings, Inc.CPHI · Drug Manufacturers - Specialty & Generic	30.54M	0.7099	−2.47%
Collegium Pharmaceutical, Inc.COLL · Drug Manufacturers - Specialty & Generic	754.96M	23.19	+0.04%

What visitors to HLS.TO's page also look at.

Company	Mkt cap	Price	Today
PROFOUND MEDICAL CORPPRN.TO	312.05M	8.54	−4.90%
MEDICENNA THERAPEUTICS CORPMDNA.TO	41.54M	0.4500	+2.27%
KNIGHT THERAPEUTICS INCGUD.TO	1.08B	11.04	+2.22%
CARERX CORPORATIONCRRX.TO	202.97M	3.2000	−2.74%
CIPHER PHARMACEUTICALS INCCPH.TO	336.75M	13.25	−2.07%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All HLS.TO news ›

Markets Daily·Oct 10Negative

HLS Therapeutics Inc. (OTCMKTS:HLTRF) Sees Significant Decline in Short Interest

Posted by Tristan Rich on Oct 10th, 2026 HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report) was the target of a large drop in short interest in September. As of September 30th, there was short interest totaling 100 shares, a drop of…

Quiver Quantitative·Oct 5Negative

$HYLN stock is down 9% today. Here's what we see in our data.

$HYLN stock has now fallen 9% today, according to our price data from Polygon. There has been approximately $6,955,313 of trading volume. Here is what we see in our data on $HYLN (you can track the company live on Quiver's $HYLN stock…

From articles in the 4Search news index.

In the news

2mentions in 30 days

1with it in the headline

Negativesentiment

Most coverage from

quiverquant.com1
themarketsdaily.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

About

Profile ›

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally. The company offers Clozaril (clozapine tablets), an atypical antipsychotic to manage symptoms of treatment-resistant schizophrenia; CSAN Pronto device, which enhances and simplifies the mandatory safety blood monitoring process for patients that are prescribed Clozaril; Nilemdo, a bemped…

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Chief executiveCraig Stuart Millian M.B.A.

Employees85

HeadquartersEtobicoke, ON, Canada

Websitehlstherapeutics.com

Analyst ratings

Analysis ›

Strong buy4 analysts

Strong buy 0
Buy 3
Hold 1
Sell 0
Strong sell 0

12-month price target7.4488+81.68%

Low 4.5125Current 4.1000High 12.1875

Wall Street analyst consensus. Not a recommendation.

Earnings

Reported EPS
Estimate

Next report: Wed, Aug 12, 2026

Quarterly results

Financials ›

Revenue
Net income
Net margin −7.0% (Q2 '26)

Prices may be delayed up to 15 min. Not investment advice.

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.